1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ARHGAP18 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA MTIF2 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA PCDHA9 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA MED11 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA AFF3 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA TSPYL4 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA TRIM22 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA PWP1 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA BLMH CTRPv2 pan-cancer AAC 0.12 0.002
mRNA AC240274.1 CTRPv2 pan-cancer AAC 0.11 0.002
Download CSV